HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 µM and 1.15 µM, respectively. Moreover, HBV-IN-25 demonstrates favorable aqueous solubility (LYSA>452 µg/mL) and no cellular toxicity, making it a promising candidate for further investigation and development [1].
Molekulargewicht:
343.76
CAS Nummer:
[2161364-69-6]
Formel:
C18H14ClNO4
Target-Kategorie:
Others|||HBV
T61115
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten